Member Info for Bladderman

If it holds?? Don't think you understand the situation lol. If the Tr1 pops up Monday it's 1p plus

Letting nothing through. Tells me the seller is history.

Fill or kill only then

NT at 0.6p

L2 flip (3-1)
Is the re-rate on.

Blue and up 5%.

Could easily do 30-40% today if seller out. This should be trading £15-£20M as fully funded til Q4 of 2023

7% of the company traded yesterday so wouldn't call that low volume.

Another excellent vid with two hot chicks....

Funded til Q4 2023 targettibg the projected £3 billion 2027 market and it's £5M

https://www.proactiveinvestors.co.uk/companies/news/991302/oxford-cannabinoid-technologies-pauses-trigeminal-neuralgia-trial-to-extend-cash-runway-991302.html

Missed 10.5p, 13p, 15p..... a comedy of errors. However this prob needs a back test to then push higher. Let's see

https://www.proactiveinvestors.co.uk/companies/news/976126/oxford-cannabinoid-technologies-hails-exciting-pre-clinical-results-for-its-lead-asset-976126.html

New agreements and partnerships signed with well-regarded organisations during the period including Aptuit (Verona) SRL (a subsidiary of Evotec SE), Oxford Stemtech Ltd., Dalriada Drug Discovery Inc., Canopy Growth Corporation and Charles Rivers Laboratories.

Evotec SE is worth £4 billion

Forward selling like that would be illegal so I'm not convinced that is the case

...and it's a £5M MCap

This could be massive

Was 3p in Feb and now we're ready to start clinical trials its 0.6p to buy....!!

Is the order filling complete now?? That trade at 0.55p could very well be a worked buy

That's over 5% TR1 is 3% so TR1 in bound- seller out...

now just under 0.6p to buy

If you have an agonist and have completed receptor bindings studies on a very well documented target and similar compounds have been in the human domain since time then it really does present an exciting proposition

On website 47.7% of shares not in public hands - wow

They had £9M in June according to accounts

Clinical trial for IBS and neuropathy associated pain from chemo will kick off in the NY.

Apparently £9M cash. No brained we know that cannaboids work at the specific receptors. As is well tolerated..!!

No brainer